Decoding ulcerative colitis: Plasma protein-mediated antibody immune responses influence disease risk

Area of Science:

• Genetics
• Immunology
• Gastroenterology

Background:

• Mendelian randomization (MR) studies have investigated plasma proteins in ulcerative colitis (UC) but haven't fully elucidated immune-mediated mechanisms.
• Understanding how plasma proteins affect UC risk via immune pathways is crucial for identifying novel therapeutic targets.

Purpose of the Study:

• To investigate the causal relationships between plasma proteins, antibody responses, and UC risk using integrated MR and mediation analysis.
• To identify specific plasma proteins and antibody responses that mediate UC risk.
• To uncover novel immuno-genetic pathways contributing to UC pathogenesis.

Main Methods:

• Utilized two-sample MR and mediation analysis on data from 4907 plasma proteins, 46 immune antibody responses, and the FinnGen consortium for UC.
• Assessed causal associations between plasma proteins, antibody responses, and UC.
• Evaluated the mediating role of antibody responses in the protein-UC risk relationship.

Main Results:

• Identified 80 plasma proteins causally associated with UC risk (P < 0.05).
• Found inverse associations between Epstein-Barr virus (EBV) EA-D antibody levels and anti-HSV-1 IgG seropositivity with UC risk.
• Five plasma proteins (UBC, TIMD4, NEFL, TMEM70, HIF1A) were linked to these antibody responses, with mediation analysis showing antibody responses explained 9.2%-13.2% of the protein effects on UC risk.

Conclusions:

• Established a novel immuno-genetic pathway in UC where plasma proteins modulate viral antibody responses, influencing disease risk.
• Identified UBC, HIF1A, and TIMD4 as potential targets for UC biomarker development and immune-focused interventions.